"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Descriptor ID |
D000959
|
MeSH Number(s) |
D27.505.954.411.162
|
Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 2 | 2 | 4 |
1996 | 5 | 4 | 9 |
1997 | 4 | 1 | 5 |
1998 | 4 | 2 | 6 |
1999 | 1 | 1 | 2 |
2000 | 9 | 3 | 12 |
2001 | 5 | 3 | 8 |
2002 | 11 | 4 | 15 |
2003 | 9 | 7 | 16 |
2004 | 9 | 8 | 17 |
2005 | 11 | 4 | 15 |
2006 | 12 | 3 | 15 |
2007 | 16 | 3 | 19 |
2008 | 17 | 4 | 21 |
2009 | 19 | 10 | 29 |
2010 | 15 | 14 | 29 |
2011 | 12 | 9 | 21 |
2012 | 17 | 6 | 23 |
2013 | 19 | 8 | 27 |
2014 | 11 | 6 | 17 |
2015 | 11 | 5 | 16 |
2016 | 10 | 5 | 15 |
2017 | 12 | 10 | 22 |
2018 | 20 | 10 | 30 |
2019 | 10 | 4 | 14 |
2020 | 5 | 6 | 11 |
2021 | 9 | 10 | 19 |
2022 | 3 | 12 | 15 |
2023 | 2 | 5 | 7 |
2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial. JAMA. 2024 03 05; 331(9):740-749.
-
Circulating microRNA Biomarkers of Thiazide Response in Hypertension. J Am Heart Assoc. 2024 Feb 20; 13(4):e032433.
-
Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 Mar; 55(3):541-547.
-
Hypertension and urologic chronic pelvic pain syndrome: An analysis of MAPP-I data. BMC Urol. 2024 Jan 28; 24(1):21.
-
Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults. J Hypertens. 2024 Apr 01; 42(4):711-717.
-
Resistant hypertension: cardiorenal protection with mineralocorticoid receptor blockade. Eur Heart J. 2024 Jan 07; 45(2):136-138.
-
Target: BP™: A National Initiative to Improve Blood Pressure Control. Hypertension. 2023 Dec; 80(12):2523-2532.
-
Blood Pressure Outcomes in NICU-Admitted Infants with Neonatal Hypertension: A Pediatric Nephrology Research Consortium Study. J Pediatr. 2024 Jan; 264:113765.
-
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023 Jul 20; 389(3):228-238.
-
Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus. J Clin Hypertens (Greenwich). 2023 08; 25(8):737-747.